Further studies will be required in larger cohorts to confirm the prognostic value of the FCGR2A rs1801274 and FCGR3A rs396991 polymorphisms and the response to ABA treatment in patients diagnosed with RA. This evidence concerns the gene FCGR3A and rheumatoid arthritis.